These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32176886)

  • 1. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
    Chari ST; Sharma A; Maitra A
    Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
    Babic A; Wolpin BM
    Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
    [No Abstract]   [Full Text] [Related]  

  • 3. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
    Crawford HC; Wallace MB; Storz P
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for Pancreatic Cancer.
    Wada K; Takaori K; Traverso LW
    Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Pancreatic Cancer: Recommendation Statement.
    Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of pancreatic cancer: working toward early detection.
    Goggins M
    Clin Cancer Res; 2011 Feb; 17(4):635-7. PubMed ID: 21304000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
    Caputo D; Caracciolo G
    Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma screening: new perspectives.
    Pezzilli R; Fabbri D; Imbrogno A
    World J Gastroenterol; 2012 Sep; 18(36):4973-7. PubMed ID: 23049204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine test can detect early stage pancreatic cancer.
    Bagcchi S
    Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer and cancer screening programs: from nihilism to hope.
    Pezzilli R; Corinaldesi R; Morselli-Labate AM
    JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
    Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer.
    Levink IJM; Nesteruk K; Visser DI; Sieuwerts AM; Fernandes CJC; Jansen MPHM; van Driel LMJW; Poley JW; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Am J Gastroenterol; 2020 Dec; 115(12):2103-2108. PubMed ID: 33105193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of sporadic pancreatic cancer: summative review.
    Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
    Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
    Kenner BJ; Chari ST; Cleeter DF; Go VL
    Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.